Physitrack (OSTO:PTRK) Other Financing: kr-2.7 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:PTRK Physitrack PLC OSTO:PTRK
64 GF Score
Price kr8.42
GF Value kr13.29
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Physitrack Other Financing?

Physitrack OSTO:PTRK -1.86% 64 Other Financing is kr-2.7 Mil as of Jun. 2026. GuruFocus rates OSTO:PTRK with a GF Score™ of 64/100 and a GF Value™ of kr13.29 (Possible Value Trap). The stock has 7 warning signs investors should review.

Physitrack's Other Financing for the three months ended in Jun. 2026 was kr-0.9 Mil.

Physitrack's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was kr-2.7 Mil.


Physitrack Other Financing Historical Data

* Premium members only.

The historical data trend for Physitrack's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Physitrack Other Financing Chart

Physitrack Annual Data
Trend Nov18 Nov19 Nov20 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial 0.00 -0.30 -3.12 -8.31 -4.04

Physitrack Quarterly Data
Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.06 -0.99 -0.77 0.00 -0.94
OSTO:PTRK
64GF Score
Physitrack PLC OSTO:PTRK
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Physitrack Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-2.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of kr-2.7 Mil mean?
Physitrack (OSTO:PTRK) has a Other Financing of kr-2.7 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Physitrack and its competitors.
Is Physitrack's Other Financing too high?
Physitrack's current Other Financing is kr-2.7 Mil. Overall, Physitrack has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Physitrack's Other Financing compare to VEEV and BTSG?
Physitrack's Other Financing of kr-2.7 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Physitrack and its competitors. Physitrack's current Other Financing is kr-2.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Physitrack stock overvalued right now?
Based on GuruFocus' analysis, Physitrack (OSTO:PTRK) is currently considered Possible Value Trap. The stock's GF Value™ is kr13.29, compared to a current price of kr8.42 — trading 36.6% below its estimated fair value. The current Other Financing is kr-2.7 Mil. Physitrack's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Physitrack (OSTO:PTRK), the current Other Financing is kr-2.7 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Physitrack (OSTO:PTRK) Overvalued in 2026?

Based on GuruFocus' analysis, Physitrack stock appears to be undervalued. The current stock price of kr8.42 is trading 36.6% below its estimated GF Value™ of kr13.29. GuruFocus considers Physitrack to be Possible Value Trap.

Key valuation signals for OSTO:PTRK:

  • Other Financing: kr-2.7 Mil
  • GF Value™: kr13.29 vs. price of kr8.42 (36.6% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the OSTO:PTRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Physitrack Business Description

Address 140 Aldersgate Street, 4th Floor, London, GBR, EC1A 4HY
Physitrack PLC is a digital healthcare and wellbeing company delivering SaaS-based solutions across two complementary divisions: i) Lifecare - supporting healthcare professionals with physiotherapy, telehealth, and patient engagement tools. ii) Wellness - delivering employee health and wellbeing solutions powered by the Champion Health platform. The majority of the company's revenue is derived from the Lifecare segment. Geographically, the company has its presence in the United Kingdom, Europe, North America and the rest of the world.
64GF Score

Get the complete analysis for OSTO:PTRK

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.42
Price
kr13.29
GF Value